Literature DB >> 19763884

A PALB2 germline mutation associated with hereditary breast cancer in Italy.

Laura Papi1, Anna Laura Putignano, Caterina Congregati, Irene Piaceri, Ines Zanna, Francesco Sera, Doralba Morrone, Maurizio Genuardi, Domenico Palli.   

Abstract

Recently, it has been demonstrated that monoallelic PALB2 mutations predispose to familial breast cancer. We investigated the contribution of PALB2 mutations in a set of 132 Italian BRCA1/BRCA2-negative breast cancer families; one truncating PALB2 mutation, c.2257C>T, resulting in p.Arg753X, was identified in a woman and her daughter, with breast cancer diagnosed at 60 and 31 years old, respectively. This study supports the recent observation that PALB2 mutation are present, although infrequently, in familial BRCA1/BRCA2-negative breast cancer cases; moreover, it sustains latest evidences that some PALB2 mutations are associated with a substantially increased risk of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763884     DOI: 10.1007/s10689-009-9295-z

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  16 in total

1.  Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

Authors:  Bing Xia; Josephine C Dorsman; Najim Ameziane; Yne de Vries; Martin A Rooimans; Qing Sheng; Gerard Pals; Abdellatif Errami; Eliane Gluckman; Julian Llera; Weidong Wang; David M Livingston; Hans Joenje; Johan P de Winter
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

2.  Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history.

Authors:  D A Berry; G Parmigiani; J Sanchez; J Schildkraut; E Winer
Journal:  J Natl Cancer Inst       Date:  1997-02-05       Impact factor: 13.506

3.  Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2.

Authors:  G Parmigiani; D Berry; O Aguilar
Journal:  Am J Hum Genet       Date:  1998-01       Impact factor: 11.025

4.  Information analysis of human splice site mutations.

Authors:  P K Rogan; B M Faux; T D Schneider
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

5.  A recurrent mutation in PALB2 in Finnish cancer families.

Authors:  Hannele Erkko; Bing Xia; Jenni Nikkilä; Johanna Schleutker; Kirsi Syrjäkoski; Arto Mannermaa; Anne Kallioniemi; Katri Pylkäs; Sanna-Maria Karppinen; Katrin Rapakko; Alexander Miron; Qing Sheng; Guilan Li; Henna Mattila; Daphne W Bell; Daniel A Haber; Mervi Grip; Mervi Reiman; Arja Jukkola-Vuorinen; Aki Mustonen; Juha Kere; Lauri A Aaltonen; Veli-Matti Kosma; Vesa Kataja; Ylermi Soini; Ronny I Drapkin; David M Livingston; Robert Winqvist
Journal:  Nature       Date:  2007-02-07       Impact factor: 49.962

6.  Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.

Authors:  María J García; Victoria Fernández; Ana Osorio; Alicia Barroso; Gemma Llort; Conxi Lázaro; Ignacio Blanco; Trinidad Caldés; Miguel de la Hoya; Teresa Ramón Y Cajal; Carmen Alonso; María-Isabel Tejada; Carlos San Román; Luis Robles-Díaz; Miguel Urioste; Javier Benítez
Journal:  Breast Cancer Res Treat       Date:  2008-02-27       Impact factor: 4.872

7.  PALB2 sequence variants in young South African breast cancer patients.

Authors:  Michelle Sluiter; Samantha Mew; Elizabeth J van Rensburg
Journal:  Fam Cancer       Date:  2009-03-31       Impact factor: 2.375

8.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

9.  Analysis of PALB2/FANCN-associated breast cancer families.

Authors:  Marc Tischkowitz; Bing Xia; Nelly Sabbaghian; Jorge S Reis-Filho; Nancy Hamel; Guilan Li; Erik H van Beers; Lili Li; Tayma Khalil; Louise A Quenneville; Atilla Omeroglu; Aletta Poll; Pierre Lepage; Nora Wong; Petra M Nederlof; Alan Ashworth; Patricia N Tonin; Steven A Narod; David M Livingston; William D Foulkes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-09       Impact factor: 11.205

10.  Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women.

Authors:  William D Foulkes; Parviz Ghadirian; Mohammed Reza Akbari; Nancy Hamel; Sylvie Giroux; Nelly Sabbaghian; Andrew Darnel; Robert Royer; Aletta Poll; Eve Fafard; André Robidoux; Ginette Martin; Tarek A Bismar; Marc Tischkowitz; Francois Rousseau; Steven A Narod
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  19 in total

1.  Novel germline PALB2 truncating mutations in African American breast cancer patients.

Authors:  Yonglan Zheng; Jing Zhang; Qun Niu; Dezheng Huo; Olufunmilayo I Olopade
Journal:  Cancer       Date:  2011-08-26       Impact factor: 6.860

2.  Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families.

Authors:  Irene Catucci; Roni Milgrom; Anya Kushnir; Yael Laitman; Shani Paluch-Shimon; Sara Volorio; Filomena Ficarazzi; Loris Bernard; Paolo Radice; Eitan Friedman; Paolo Peterlongo
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

3.  Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation.

Authors:  Maria Teresa Vietri; Gemma Caliendo; Concetta Schiano; Amelia Casamassimi; Anna Maria Molinari; Claudio Napoli; Michele Cioffi
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

4.  Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.

Authors:  Silvia Casadei; Barbara M Norquist; Tom Walsh; Sunday Stray; Jessica B Mandell; Ming K Lee; John A Stamatoyannopoulos; Mary-Claire King
Journal:  Cancer Res       Date:  2011-02-01       Impact factor: 12.701

5.  PALB2 c.2257C>T truncating variant is a Greek founder and is associated with high breast cancer risk.

Authors:  Andromachi Vagena; Myrto Papamentzelopoulou; Despoina Kalfakakou; Panagoula Kollia; Christos Papadimitriou; Amanda Psyrri; Paraskevi Apostolou; George Fountzilas; Irene Konstantopoulou; Drakoulis Yannoukakos; Florentia Fostira
Journal:  J Hum Genet       Date:  2019-05-14       Impact factor: 3.172

Review 6.  PALB2/FANCN: recombining cancer and Fanconi anemia.

Authors:  Marc Tischkowitz; Bing Xia
Journal:  Cancer Res       Date:  2010-09-21       Impact factor: 12.701

7.  PALB2: a novel inactivating mutation in a Italian breast cancer family.

Authors:  Cristina Balia; Elisa Sensi; Grazia Lombardi; Manuela Roncella; Generoso Bevilacqua; Maria Adelaide Caligo
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

8.  Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families.

Authors:  Zhi L Teo; Daniel J Park; Elena Provenzano; Catherine A Chatfield; Fabrice A Odefrey; Tu Nguyen-Dumont; James G Dowty; John L Hopper; Ingrid Winship; David E Goldgar; Melissa C Southey
Journal:  Breast Cancer Res       Date:  2013-02-28       Impact factor: 6.466

9.  A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype.

Authors:  Ingo Ruczinski; Timothy J Jorgensen; Yin Yao Shugart; Yvette Berthier Schaad; Bailey Kessing; Judith Hoffman-Bolton; Kathy J Helzlsouer; W H Linda Kao; Lee Wheless; Lesley Francis; Rhoda M Alani; Paul T Strickland; Michael W Smith; Anthony J Alberg
Journal:  Carcinogenesis       Date:  2012-05-11       Impact factor: 4.944

10.  Inherited and acquired alterations in development of breast cancer.

Authors:  Piera Rizzolo; Valentina Silvestri; Mario Falchetti; Laura Ottini
Journal:  Appl Clin Genet       Date:  2011-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.